Literature DB >> 9566586

Effects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia.

A Regner1, G Ramirez, A Belló-Klein, D Souza.   

Abstract

Glutamate significantly increased levels of spontaneous chemiluminescence (CL) in rat hippocampal slices incubated under hypoxic conditions. Although it has been previously shown that guanine nucleotides (GN) displace glutamate from several of its receptors, in our study only GMP, as well as the glutamate antagonist MK-801, was able to reverse the increase in CL provoked by glutamate. On the other hand, not only GTP or Gpp(NH)p failed to reverse the action of glutamate, but they increased CL production like glutamate. This effect of GTP/Gpp(NH)p was also reversed by GMP. We concluded that, under neurotoxic conditions, GMP acted as an antagonist and GTP or Gpp(NH)p acted as agonists of glutamate. These results reinforced the evidence of the existence of extracellular site(s) for GN and indicated a possible role for GN in excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566586     DOI: 10.1023/a:1022430501454

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

Review 1.  G proteins.

Authors:  J R Hepler; A G Gilman
Journal:  Trends Biochem Sci       Date:  1992-10       Impact factor: 13.807

2.  GMP reverses the facilitatory effect of glutamate on inhibitory avoidance task in rats.

Authors:  M A Rubin; A Jurach; E M da Costa Júnior; T T Lima; R E Jiménez-Bernal; J Begnini; D O Souza; C F de Mello
Journal:  Neuroreport       Date:  1996-09-02       Impact factor: 1.837

3.  Specific binding of [3H]GppNHp to extracellular membrane receptors in chick cerebellum: possible involvement of kainic acid receptors.

Authors:  M Ramos; D O Souza; G Ramírez
Journal:  FEBS Lett       Date:  1997-04-07       Impact factor: 4.124

4.  Metabolic stability of hippocampal slice preparations during prolonged incubation.

Authors:  T S Whittingham; W D Lust; D A Christakis; J V Passonneau
Journal:  J Neurochem       Date:  1984-09       Impact factor: 5.372

Review 5.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  NMDA-dependent superoxide production and neurotoxicity.

Authors:  M Lafon-Cazal; S Pietri; M Culcasi; J Bockaert
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

7.  Reoxygenation injury in isolated rat hepatocytes: relation to oxygen free radicals and lipid peroxidation.

Authors:  P Caraceni; E R Rosenblum; D H Van Thiel; A B Borle
Journal:  Am J Physiol       Date:  1994-05

8.  Modulation of adenosine-induced cAMP accumulation via metabotropic glutamate receptors in chick optic tectum.

Authors:  C I Tasca; D Vendite; L H Martini; L F Cardoso; D O Souza
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

9.  Involvement of free radicals in excitotoxicity in vivo.

Authors:  J B Schulz; D R Henshaw; D Siwek; B G Jenkins; R J Ferrante; P B Cipolloni; N W Kowall; B R Rosen; M F Beal
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  10 in total

1.  Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia.

Authors:  Ivaldo J L Oliveira; Simone Molz; Diogo O Souza; Carla I Tasca
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  Effects of 3 weeks GMP oral administration on glutamatergic parameters in mice neocortex.

Authors:  Marcelo Ganzella; Julia Dubois Moreira; Roberto Farina Almeida; Ana Elisa Böhmer; Jonas Alex Morales Saute; Silvia Holmseth; Diogo Onofre Souza
Journal:  Purinergic Signal       Date:  2011-09-01       Impact factor: 3.765

3.  Investigations into the mechanism of 2,3-dimercaptopropanol neurotoxicity.

Authors:  C W Nogueira; F A Soares; R C Bolzan; M C Jacques-Silva; D O Souza; J B Rocha
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

4.  HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?

Authors:  Andrea Regner; Ottomar Bianchini; Claudio Jardim; Marcio Menna-Barreto
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

5.  Interaction of adenosine and guanine derivatives in the rat hippocampus: effects on cyclic AMP levels and on the binding of adenosine analogues and GMP.

Authors:  C I Tasca; D O Souza
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

6.  Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice.

Authors:  A P Schmidt; A E Böhmer; C Schallenberger; C Antunes; R G Tavares; S T Wofchuk; E Elisabetsky; D O Souza
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

7.  Neurotoxicity induced by glutamate in glucose-deprived rat hippocampal slices is prevented by GMP.

Authors:  Simone Molz; Helena Decker; Ivaldo J L Oliveira; Diogo O Souza; Carla I Tasca
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

8.  Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice.

Authors:  André P Schmidt; Thiago T Avila; Diogo O Souza
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 9.  Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.

Authors:  Débora Lanznaster; Tharine Dal-Cim; Tetsadê C B Piermartiri; Carla I Tasca
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

Review 10.  Neuromodulatory Effects of Guanine-Based Purines in Health and Disease.

Authors:  Carla I Tasca; Débora Lanznaster; Karen A Oliveira; Victor Fernández-Dueñas; Francisco Ciruela
Journal:  Front Cell Neurosci       Date:  2018-10-23       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.